Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cardiac Catheterization III: Left Heart Catheterization

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...

Acute Coronary Syndrome III: Diagnostic Studies

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...

Coronary Artery Disease V: Interprofessional Care

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...

Acute Coronary Syndrome V: Nursing Management

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Microbial Colonization of Capsular Traction Sutures in Hip Arthroscopic Surgery.

Orthopaedic journal of sports medicine·2023

Same author

Possible role of frankincense in the treatment of benign essential blepharospasm.

American journal of ophthalmology case reports·2023

Same author

Arthroscopic Ankle Arthrodesis.

Clinics in podiatric medicine and surgery·2023

Same author

Over 50% of Studies Report Low-Back Pain Is Associated With Worse Outcomes After Hip Arthroscopy When Compared With a Control Group: A Systematic Review.

Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association·2023

Same author

Current Status of Cardiovascular Disease According to the Duration of Hypertension in Korean Adults.

Global heart·2023

Same author

Does Intracranial Pressure Influence the Development of Glaucoma?

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2023

Search research articles

Related Experiment Video

Updated: May 8, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Unprotected left main PCI: status report 2013.

Jared Oyama¹, Michael S Lee

¹Department of Medicine, Division of Interventional Cardiology, UCLA Medical Center, Los Angeles, California, USA.

The Journal of Invasive Cardiology

|September 3, 2013

Summary

Unprotected left main coronary artery (ULMCA) disease treatment is evolving. Percutaneous coronary intervention (PCI) is increasingly supported for select patients, with ongoing trials comparing it to traditional bypass surgery.

More Related Videos

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft

Published on: September 15, 2023

Related Experiment Videos

Last Updated: May 8, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft

Published on: September 15, 2023

Area of Science:

Cardiovascular Medicine
Interventional Cardiology
Clinical Trials

Background:

Unprotected left main coronary artery (ULMCA) disease affects 4% of patients undergoing angiography.
Coronary artery bypass graft surgery (CABG) has been the gold standard for revascularization.
Recent guidelines acknowledge percutaneous coronary intervention (PCI) as a viable option for select ULMCA patients.

Purpose of the Study:

To review current literature on the efficacy of ULMCA PCI.
To discuss contemporary strategies for evaluating and treating ULMCA disease percutaneously.
To highlight the significance of the ongoing EXCEL trial in comparing ULMCA PCI with CABG.

Main Methods:

Review of recent clinical studies and major society guidelines.
Analysis of contemporary approaches to ULMCA disease evaluation.
Focus on percutaneous coronary intervention (PCI) techniques for ULMCA treatment.

Main Results:

Evidence suggests PCI is effective in properly selected ULMCA patients.
Contemporary evaluation and treatment strategies are refining patient selection for PCI.
The EXCEL trial is crucial for definitive comparison between ULMCA PCI and CABG.

Conclusions:

PCI is a growing alternative to CABG for ULMCA disease in select populations.
Further evidence from trials like EXCEL is needed to fully establish the role of ULMCA PCI.
Personalized treatment strategies are essential for managing ULMCA disease.